TapewireFind a company

person · Reporting owner

Yednock Ted

Disclosed activity across 1 company

Tapewire entity
38211
SEC CIK
0001818525

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Annexon, Inc.ANNX · Entity 5011EVP & CHIEF INNOVATION OFFICERJune 11, 2026June 15, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Annexon, Inc.

Report date June 11, 2026 · Filed June 15, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect184,807 Reported balance After 2026-06-11 transaction · row 1
1 source row

Row 1 · 2026-06-11 · Exercise / conversion · Acquired 30,646 · Balance 184,807

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2026-08-11Direct0 Reported balance After 2026-06-11 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-06-11 · Exercise / conversion · Disposed 30,646 · Balance 0

F1: The shares subject to the option are fully vested and exercisable.

Filing footnotes · ownership attribution and instrument terms

F1: The shares subject to the option are fully vested and exercisable.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 11, 2026 Filed Jun 15, 2026 20:15 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionStock Option (Right to Buy) · Derivative 30,646 $0.00 Strike: $1.85 $0.00
Disclosure

SEC source: 0001818525-26-000004 · form4-06152026_040601.xml · derivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,646 shares

Expires 2026-08-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 20:15 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionCommon Stock 30,646 $1.85 $56,698.16
Disclosure

SEC source: 0001818525-26-000004 · form4-06152026_040601.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,807

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:30 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 5,566 $5.42 $30,167.72
Disclosure

SEC source: 0001818525-26-000003 · form4-03042026_040338.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,161

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $5.35 to $5.57, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 19, 2026 Filed Feb 24, 2026 00:05 UTC Annexon, Inc. ANNX · Entity 5011 GrantStock Option (Right to Buy) · Derivative 250,000 $0.00 Strike: $5.10 $0.00
Disclosure

SEC source: 0001818525-26-000002 · form4-02242026_120245.xml · derivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2036-02-19

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 19, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
February 19, 2026 Filed Feb 24, 2026 00:05 UTC Annexon, Inc. ANNX · Entity 5011 GrantCommon Stock 62,500 $0.00 $0.00
Disclosure

SEC source: 0001818525-26-000002 · form4-02242026_120245.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,727

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 19 of each year, with the first 1/3rd vesting on February 19, 2027, subject to Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 21:30 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 7,857 $5.11 $40,149.27
Disclosure

SEC source: 0001818525-26-000001 · form4-02202026_040207.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,227

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $4.925 to $5.17, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
July 14, 2025 Filed Jul 16, 2025 20:20 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 1,116 $2.58 $2,879.28
Disclosure

SEC source: 0001415889-25-019838 · form4-07162025_040706.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,084

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.57 to $2.64, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 21:48 UTC Annexon, Inc. ANNX · Entity 5011 GrantStock Option (Right to Buy) · Derivative 272,575 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-25-006191 · form4-03032025_090340.xml · derivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,575

Underlying: Common Stock · 272,575 shares

Expires 2034-02-27

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 27, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:51 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 8,345 $2.91 $24,283.95
Disclosure

SEC source: 0001415889-25-004888 · form4-02202025_090206.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,237

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.77 to $3.1376, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 1,783 $2.99 $5,331.17
Disclosure

SEC source: 0001415889-25-004432 · form4-02182025_040203.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,582

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.895 to $3.0297, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 21:09 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionStock Option (Right to Buy) · Derivative 5,408 $0.00 Strike: $1.85 $0.00
Disclosure

SEC source: 0001415889-24-025382 · form4-10172024_091004.xml · derivative · entry 3

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,646

Underlying: Common Stock · 5,408 shares

Expires 2026-08-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 21:09 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 5,408 $7.41 $40,073.28
Disclosure

SEC source: 0001415889-24-025382 · form4-10172024_091004.xml · nonDerivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,365

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 21:09 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionCommon Stock 5,408 $1.85 $10,005.34
Disclosure

SEC source: 0001415889-24-025382 · form4-10172024_091004.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2024 Filed Sep 20, 2024 20:30 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 4,500 $7.10 $31,950.00
Disclosure

SEC source: 0001415889-24-023771 · form4-09202024_040902.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 0

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 20:30 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 5,500 $6.16 $33,880.00
Disclosure

SEC source: 0001415889-24-023441 · form4-09162024_040901.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 4,500

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024.

Read SEC document
September 05, 2024 Filed Sep 6, 2024 20:30 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 5,500 $5.64 $31,020.00
Disclosure

SEC source: 0001415889-24-023018 · form4-09062024_040902.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 10,000

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024.

Read SEC document
August 29, 2024 Filed Aug 30, 2024 22:00 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 5,500 $5.95 $32,725.00
Disclosure

SEC source: 0001415889-24-022645 · form4-08302024_100809.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 15,500

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 20:46 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 1,106 $6.02 $6,658.12
Disclosure

SEC source: 0001415889-24-019677 · form4-07172024_080745.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,365

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $5.97 to $6.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 27, 2024 Filed Mar 3, 2025 21:48 UTC Annexon, Inc. ANNX · Entity 5011 GrantCommon Stock 44,963 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-006191 · form4-03032025_090340.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,200

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 27 of each year, with the first 1/3rd vesting on February 27, 2026.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 21:31 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 2,604 $5.51 $14,348.04
Disclosure

SEC source: 0001415889-24-004625 · form4-02212024_040217.xml · nonDerivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,471

F2 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of RSUs.

F3 · price: This transaction was executed in multiple trades in prices ranging from $5.34 to $5.58, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 21:31 UTC Annexon, Inc. ANNX · Entity 5011 GrantStock Option (Right to Buy) · Derivative 160,000 $0.00 Strike: $5.13 $0.00
Disclosure

SEC source: 0001415889-24-004625 · form4-02212024_040217.xml · derivative · entry 4

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2034-02-16

F4 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 16, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 21:31 UTC Annexon, Inc. ANNX · Entity 5011 GrantCommon Stock 39,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-004625 · form4-02212024_040217.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,075

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 16 of each year, with the first 1/3rd vesting on February 16, 2025.

Read SEC document
February 12, 2024 Filed Feb 15, 2024 00:52 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 1,810 $5.54 $10,027.40
Disclosure

SEC source: 0001415889-24-003854 · form4-02152024_120219.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,075

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $5.33 to $5.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3 · balance_after: Includes 29,392 RSUs.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 21:12 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionStock Option (Right to Buy) · Derivative 10,385 $0.00 Strike: $1.85 $0.00
Disclosure

SEC source: 0001209191-23-059988 · doc4.xml · derivative · entry 5

Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 10,385 shares

Expires 2026-08-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023.

F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 21:12 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionStock Option (Right to Buy) · Derivative 10,615 $0.00 Strike: $1.41 $0.00
Disclosure

SEC source: 0001209191-23-059988 · doc4.xml · derivative · entry 4

Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,615 shares

Expires 2025-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023.

F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 21:12 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 21,000 $4.52 $94,966.20
Disclosure

SEC source: 0001209191-23-059988 · doc4.xml · nonDerivative · entry 3

Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023.

F2 · price: This transaction was executed in multiple trades in prices ranging from $4.50 to $4.58, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 21:12 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionCommon Stock 10,385 $1.85 $19,213.29
Disclosure

SEC source: 0001209191-23-059988 · doc4.xml · nonDerivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 21:12 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionCommon Stock 10,615 $1.41 $14,962.90
Disclosure

SEC source: 0001209191-23-059988 · doc4.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,615

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023.

Read SEC document
December 27, 2023 Filed Jan 23, 2024 22:00 UTC Amendment Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 21,000 $4.52 $94,966.20
Disclosure

SEC source: 0001209191-24-002080 · doc4a.xml · nonDerivative · entry 4

Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,885

F5 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023.

F3 · price: This transaction was executed in multiple trades in prices ranging from $3.72 to $3.90, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4 · balance_after: Includes 33,559 restricted stock units.

F6 · balance_after: Column 5 is being amended to reflect the correct amount of securities beneficially owned following reported transaction.

Read SEC document
December 27, 2023 Filed Jan 23, 2024 22:00 UTC Amendment Annexon, Inc. ANNX · Entity 5011 Exercise / conversionCommon Stock 10,385 $1.85 $19,213.29
Disclosure

SEC source: 0001209191-24-002080 · doc4a.xml · nonDerivative · entry 3

Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,885

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023.

F4 · balance_after: Includes 33,559 restricted stock units.

F6 · balance_after: Column 5 is being amended to reflect the correct amount of securities beneficially owned following reported transaction.

Read SEC document
December 27, 2023 Filed Jan 23, 2024 22:00 UTC Amendment Annexon, Inc. ANNX · Entity 5011 Exercise / conversionCommon Stock 10,615 $1.41 $14,962.90
Disclosure

SEC source: 0001209191-24-002080 · doc4a.xml · nonDerivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023.

F4 · balance_after: Includes 33,559 restricted stock units.

F6 · balance_after: Column 5 is being amended to reflect the correct amount of securities beneficially owned following reported transaction.

Read SEC document
July 11, 2023 Filed Jan 23, 2024 22:00 UTC Amendment Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 1,057 $3.84 $4,054.76
Disclosure

SEC source: 0001209191-24-002080 · doc4a.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,885

F1 · security: Late reporting of transaction being made as a result of an administrative oversight.

F2 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F3 · price: This transaction was executed in multiple trades in prices ranging from $3.72 to $3.90, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4 · balance_after: Includes 33,559 restricted stock units.

Read SEC document
September 13, 2021 Filed Sep 15, 2021 22:35 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionStock Option (Right to Buy) · Derivative 1,190 $0.00 Strike: $5.11 $0.00
Disclosure

SEC source: 0001567619-21-017166 · doc1.xml · derivative · entry 5

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,939

Underlying: Common Stock · 1,190 shares

Expires 2029-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from December 12, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
September 13, 2021 Filed Sep 15, 2021 22:35 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $1.41 $0.00
Disclosure

SEC source: 0001567619-21-017166 · doc1.xml · derivative · entry 4

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,615

Underlying: Common Stock · 15,000 shares

Expires 2025-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable.

Read SEC document
September 13, 2021 Filed Sep 15, 2021 22:35 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 16,190 $20.00 $323,859.90
Disclosure

SEC source: 0001567619-21-017166 · doc1.xml · nonDerivative · entry 3

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades in prices ranging from $20.00 to $20.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 13, 2021 Filed Sep 15, 2021 22:35 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionCommon Stock 1,190 $5.11 $6,080.66
Disclosure

SEC source: 0001567619-21-017166 · doc1.xml · nonDerivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 13, 2021 Filed Sep 15, 2021 22:35 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionCommon Stock 15,000 $1.41 $21,144.00
Disclosure

SEC source: 0001567619-21-017166 · doc1.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 03, 2021 Filed Jun 7, 2021 20:47 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $1.41 $0.00
Disclosure

SEC source: 0001567619-21-011776 · doc1.xml · derivative · entry 4

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,615

Underlying: Common Stock · 15,000 shares

Expires 2025-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable.

Read SEC document
June 03, 2021 Filed Jun 7, 2021 20:47 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 2,184 $21.72 $47,440.85
Disclosure

SEC source: 0001567619-21-011776 · doc1.xml · nonDerivative · entry 3

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades in prices ranging from $21.665 to $21.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
June 03, 2021 Filed Jun 7, 2021 20:47 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 12,816 $21.45 $274,883.98
Disclosure

SEC source: 0001567619-21-011776 · doc1.xml · nonDerivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,184

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades in prices ranging from $20.67 to $21.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
June 03, 2021 Filed Jun 7, 2021 20:47 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionCommon Stock 15,000 $1.41 $21,144.00
Disclosure

SEC source: 0001567619-21-011776 · doc1.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 25, 2021 Filed Mar 29, 2021 21:10 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionStock Option (Right to Buy) · Derivative 1,175 $0.00 Strike: $5.11 $0.00
Disclosure

SEC source: 0001567619-21-007133 · doc1.xml · derivative · entry 7

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,129

Underlying: Common Stock · 1,175 shares

Expires 2029-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from December 12, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
March 25, 2021 Filed Mar 29, 2021 21:10 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $1.41 $0.00
Disclosure

SEC source: 0001567619-21-007133 · doc1.xml · derivative · entry 6

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,615

Underlying: Common Stock · 15,000 shares

Expires 2025-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable.

Read SEC document
March 25, 2021 Filed Mar 29, 2021 21:10 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 237 $29.96 $7,100.52
Disclosure

SEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 5

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document
March 25, 2021 Filed Mar 29, 2021 21:10 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 5,680 $29.21 $165,913.94
Disclosure

SEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 4

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades in prices ranging from $28.92 to $29.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
March 25, 2021 Filed Mar 29, 2021 21:10 UTC Annexon, Inc. ANNX · Entity 5011 SaleCommon Stock 10,258 $28.54 $292,755.11
Disclosure

SEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 3

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,917

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades in prices ranging from $27.91 to $28.89, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
March 25, 2021 Filed Mar 29, 2021 21:10 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionCommon Stock 1,175 $5.11 $6,004.02
Disclosure

SEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 25, 2021 Filed Mar 29, 2021 21:10 UTC Annexon, Inc. ANNX · Entity 5011 Exercise / conversionCommon Stock 15,000 $1.41 $21,144.00
Disclosure

SEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 01:07 UTC Annexon, Inc. ANNX · Entity 5011 GrantStock Option (Right to Buy) · Derivative 115,000 $0.00 Strike: $30.07 $0.00
Disclosure

SEC source: 0001567619-21-005222 · doc1.xml · derivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2031-02-25

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 25, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.